BODYCOTE PLC (`the Company') Directorate Change - Change in Director's Particulars 5 March 2014 In accordance with paragraph 9.6.14 of the Listing Rules, the Company advises that it has today been notified that John Biles, Non-Executive Director, has been appointed as a Non-Executive Director of Skyepharma PLC with effect from 5 March 2014. Contact for queries:
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
694 GBX | -0.29% | 0.00% | +16.74% |
May. 01 | EXECUTIVE CHANGES: New chairs for CVS Group, LSL Property and Videndum | AN |
Apr. 03 | Jefferies Raises Bodycote PT, Maintains Buy Rating | MT |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+16.74% | 1.64B | |
+12.62% | 82.74B | |
+17.86% | 69.97B | |
+20.14% | 37.66B | |
+14.52% | 31.6B | |
+12.66% | 27.79B | |
+2.46% | 26.5B | |
+17.57% | 25.66B | |
+2.11% | 25.43B | |
+15.63% | 24.64B |
- Stock Market
- Equities
- BOY Stock
- News Bodycote plc
- Bodycote PLC : - Change in Director's Particulars